ERBB2 and breast cancer: demonstrated that a higher number of infiltrating FoxP3-positive T cells in breast cancer patients was associated with a lower overall survival rate and was significantly associated with a positive human epidermal growth factor receptor 2 (HER2) status, a positive lymph node status, and negative estrogen receptor (ER) status (52).